Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study.

@article{Nupur2018AssessmentOS,
  title={Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study.},
  author={Neh Nupur and Nidhi Chhabra and Rozaleen Dash and Anurag S. Rathore},
  journal={mAbs},
  year={2018},
  volume={10 1},
  pages={143-158}
}
Biosimilars are products that are similar in terms of quality, safety, and efficacy to an already licensed reference/ innovator product and are expected to offer improved affordability. The most significant source of reduction in the cost of development of a biosimilar is the reduced clinical examination that it is expected to undergo as compared to the… CONTINUE READING